AKT1 and hemangioma: Induced inhibition of hemangioma endothelial cell proliferation and migration by inhibiting AKT1 and p38MAPK pathways [21] in a dose dependent manner is unable to suppress clonogenic GLUT1-positive HemSCs, which have the ability to continuously differentiate into other proliferating hemangioma endothelial cells [33].